Cargando…
Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats
Nerve growth factor (NGF) is essential for the survival of sensory and sympathetic neurons during development. However, in the adult, NGF and its interaction with tropomyosin receptor kinase A receptor (TrkA) has been found to play a critical role in nociception and nervous system plasticity in pain...
Autores principales: | Enomoto, Masataka, Mantyh, Patrick W, Murrell, Joanna, Innes, John F, Lascelles, B Duncan X |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326241/ https://www.ncbi.nlm.nih.gov/pubmed/30368458 http://dx.doi.org/10.1136/vr.104590 |
Ejemplares similares
-
Frunevetmab, a felinized anti‐nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats
por: Gruen, Margaret E., et al.
Publicado: (2021) -
Development of a checklist for the detection of degenerative joint
disease-associated pain in cats
por: Enomoto, Masataka, et al.
Publicado: (2020) -
In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti‐Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats
por: Gearing, D.P., et al.
Publicado: (2016) -
A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain
por: Lascelles, B Duncan X, et al.
Publicado: (2015) -
Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study
por: Gruen, Margaret E., et al.
Publicado: (2021)